Phosphorylated LASS2 inhibits prostate carcinogenesis via negative regulation of Wnt/ß-catenin signaling.

Zhang, Kuangen; Wu, Rui; Mei, Fang; Zhou, Yuhe; He, Lin; Liu, Yanhua; Zhao, Xuyang; You, Jiangfeng; Liu, Beiying; Meng, Qingyang; Pei, Fei

Zhang, Kuangen; Wu, Rui; Mei, Fang; Zhou, Yuhe; He, Lin; Liu, Yanhua; Zhao, Xuyang; You, Jiangfeng; Liu, Beiying; Meng, Qingyang; Pei, Fei.

Affiliation

Zhang K; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Wu R; Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Mei F; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Zhou Y; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
He L; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Liu Y; Physiatry Department, Beijing Cancer Hospital, Beijing, China.
Zhao X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing, China.
You J; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Liu B; Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Meng Q; Department of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Pei F; School of Mechanical Engineering, University of Science and Technology Beijing, Beijing, China.